Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study.
about
Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Safety and efficacy of rituxim ...... trospective multicenter study.
@en
Safety and efficacy of rituxim ...... trospective multicenter study.
@nl
type
label
Safety and efficacy of rituxim ...... trospective multicenter study.
@en
Safety and efficacy of rituxim ...... trospective multicenter study.
@nl
prefLabel
Safety and efficacy of rituxim ...... trospective multicenter study.
@en
Safety and efficacy of rituxim ...... trospective multicenter study.
@nl
P2093
P2860
P50
P1433
P1476
Safety and efficacy of rituxim ...... etrospective multicenter study
@en
P2093
Alberto Santagostino
Annalisa Arcari
Daniele Vallisa
Dario Marino
Fiorella Ilariucci
Francesco Ghio
Giuseppe Carli
Luca Zanlari
Maria Giuseppina Cabras
Massimo Gentile
P2860
P304
P356
10.3109/10428194.2015.1106536
P577
2015-12-15T00:00:00Z